Recursion, a biotechnology company scaling more like a technology company, today announced the appointment of Louisa Daniels, J.D., MBA as its Chief Legal Officer and General Counsel. In her new role, Daniels will oversee Recursion’s legal and compliance functions and augment Recursion’s industry-leading executive team.
With more than 20 years in senior roles in the biopharma industry, Daniels joins Recursion from Pfizer Inc., where she served as Vice President & Assistant General Counsel. In that position, Daniels was head of the clinical development legal team and had a leading role in legal support for Pfizer’s COVID-19 vaccine program, Operation Light Speed.
Daniels previously served as Vice President & Assistant General Counsel at Pfizer from April 2008 to January 2021, where she also served as Chief Counsel of Global Product Development from May 2016 to January 2021, as Chief Counsel of Global Commercial Operations, Strategy & Portfolio Management from 2013 to 2016 and as Lead Counsel of PharmaTherapeutics R&D from 2008 to 2013. Ms. Daniels obtained her J.D. from the University of California, BerkeleySchool of Law and her M.B.A from the Paul Merage School of Business at University of California, Irvine.